阿尔茨海默病蛋白或成慢性创伤性脑病诊断新线索

An Alzheimer’s protein might help ID another brain disease By RJ Mackenzie For people with chronic traumatic encephalopathy, or CTE, diagnosis comes only after death, when the brain can be examined during autopsy. But repurposing a biomarker for Alzheimer’s disease might someday bring testing to the living. In a study of deceased individuals confirmed to have CTE, those with advanced disease had high levels of an Alzheimer’s-associated protein in the brain and blood, neuroscientist Chihiro Sato and colleagues reported at the Alzheimer’s Association International Conference in London. …